Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study


ARTAÇ M., Turha N. S. , Kocer M., KARABULUT B., Bozcuk H., Yalcin S., ...More

TUMORI JOURNAL, vol.100, no.2, pp.143-148, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 100 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1700/1491.16397
  • Title of Journal : TUMORI JOURNAL
  • Page Numbers: pp.143-148

Abstract

Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer.